-
AKRO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
04 May 2024 17:04 GMT
… -induced cirrhosis. The Akero class action lawsuit alleges that defendants throughout … extensive experience in prosecuting investor class actions including actions involving financial … securities class action recovery ever – $7.2 billion – in In re Enron Corp …
-
INVESTOR DEADLINE APPROACHING: Robbins Geller Rudman & Dowd LLP Announces that The Chemours Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - CC
04 May 2024 13:55 GMT
… lead plaintiff of the Chemours class action lawsuit, please provide your information … specialty chemical company. The Chemours class action lawsuit alleges that defendants made … securities class action recovery ever – $7.2 billion – in In re Enron Corp …
-
LNC INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lincoln National Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
04 May 2024 09:30 GMT
… plaintiff of the Lincoln National class action lawsuit, please provide your … subsidiary companies. The Lincoln National class action lawsuit alleges that defendants throughout … securities class action recovery ever – $7.2 billion – in In re Enron Corp …
-
AKRO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
02 May 2024 20:11 GMT
… -induced cirrhosis.
The Akero class action lawsuit alleges that defendants throughout … extensive experience in prosecuting investor class actions including actions involving financial … securities class action recovery ever – $7.2 billion – in In re Enron Corp …
-
AKRO INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
01 May 2024 15:41 GMT
… -induced cirrhosis. The Akero class action lawsuit alleges that defendants throughout … extensive experience in prosecuting investor class actions including actions involving financial … securities class action recovery ever – $7.2 billion – in In re Enron Corp …
-
MBUU INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Malibu Boats, Inc. Investors with Substantial Losses Have Opportunity to Lead the Malibu Boats Class Action Lawsuit
30 Apr 2024 00:32 GMT
… that the Malibu Boats class action lawsuit seeks to represent … of the Malibu Boats class action lawsuit, please provide your … world’s leading complex class action firms representing plaintiffs in … class action recovery ever – $7.2 billion – in In re Enron …
-
GDRX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
29 Apr 2024 14:00 GMT
… , according to GoodRx class action lawsuit.
Then, the GoodRx class action lawsuit further alleges … the world’s leading complex class action firms representing plaintiffs in securities … securities class action recovery ever – $7.2 billion – in In re Enron Corp …
-
ADSK INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Autodesk, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
29 Apr 2024 14:00 GMT
… media, and entertainment.”
The Autodesk class action lawsuit alleges that defendants throughout … to the Autodesk class action lawsuit.
Then, the Autodesk class action lawsuit further … securities class action recovery ever – $7.2 billion – in In re Enron Corp …
-
LNC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Lincoln National Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
29 Apr 2024 13:05 GMT
… plaintiff of the Lincoln National class action lawsuit, please provide your … subsidiary companies. The Lincoln National class action lawsuit alleges that defendants throughout … securities class action recovery ever – $7.2 billion – in In re Enron Corp …
-
AKRO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
29 Apr 2024 11:56 GMT
… -induced cirrhosis.
The Akero class action lawsuit alleges that defendants throughout … extensive experience in prosecuting investor class actions including actions involving financial … securities class action recovery ever – $7.2 billion – in In re Enron Corp …